Crohn’s Disease Study - Maestro Study

Did you know? Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease (CD), affects about 5 million people worldwide. While there are multiple treatments available, for many people these treatments only partially work, do not work, or stop working. As a result, there is a real need to develop more treatment options.

Doctors are researching an investigational medication designed to specifically treat UC and CD symptoms. If you are 18–75 years of age and have been diagnosed with moderate to severe UC or CD, you may be eligible to enroll in the Maestro clinical research study.

• For more information Contact Us.